Literature DB >> 24077929

Opioid analgesic misuse is associated with incomplete antiretroviral adherence in a cohort of HIV-infected indigent adults in San Francisco.

Sara Jeevanjee, Joanne Penko, David Guzman, Christine Miaskowski, David R Bangsberg, Margot B Kushel.   

Abstract

There is little or no data examining the association between either pain or the use or misuse of opioid analgesic with adherence to antiretroviral medications (ARVs) among HIV-infected adults. We interviewed a community-based cohort of HIV-infected indigent adults prescribed antiretroviral medications (ARVs) quarterly to examine the association between (1) pain, (2) receipt of opioid analgesics, and (3) opioid analgesic misuse with self-reported ARV adherence. Of 281 participants, most (82.5 %) reported severe or moderate pain, half (52.4 %) received a prescription for opioids, and one quarter (24.6 %) misused opioid analgesics. Most (71.9 %) reported >90 % ARV adherence. In a GEE model, neither pain (unadjusted OR 1.14, CI 0.90–1.45) nor prescription of opioid analgesics (unadjusted OR 1.11, CI 0.84–1.49) were significantly associated with ARV adherence. Misuse of opioid analgesics was associated with incomplete adherence (AOR 1.42, CI 1.09–1.86). Individuals who misuse opioid analgesics, like those who use illicit substances, may have difficulty adhering to medication regimens.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24077929      PMCID: PMC3969410          DOI: 10.1007/s10461-013-0619-5

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  62 in total

1.  Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring.

Authors:  J H Arnsten; P A Demas; H Farzadegan; R W Grant; M N Gourevitch; C J Chang; D Buono; H Eckholdt; A A Howard; E E Schoenbaum
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

2.  Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users.

Authors:  Grace E Macalino; David D Celentano; Carl Latkin; Steffanie A Strathdee; David Vlahov
Journal:  AIDS Educ Prev       Date:  2002-10

Review 3.  Opioid therapy for chronic pain.

Authors:  Jane C Ballantyne; Jianren Mao
Journal:  N Engl J Med       Date:  2003-11-13       Impact factor: 91.245

4.  Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. The Manif 2000 study group.

Authors:  J P Moatti; M P Carrieri; B Spire; J A Gastaut; J P Cassuto; J Moreau
Journal:  AIDS       Date:  2000-01-28       Impact factor: 4.177

5.  The effect of chronic pain on diabetes patients' self-management.

Authors:  Sarah L Krein; Michele Heisler; John D Piette; Fatima Makki; Eve A Kerr
Journal:  Diabetes Care       Date:  2005-01       Impact factor: 19.112

6.  Adherence to protease inhibitor therapy and outcomes in patients with HIV infection.

Authors:  D L Paterson; S Swindells; J Mohr; M Brester; E N Vergis; C Squier; M M Wagener; N Singh
Journal:  Ann Intern Med       Date:  2000-07-04       Impact factor: 25.391

7.  The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials.

Authors:  Sharon Mannheimer; Gerald Friedland; John Matts; Carroll Child; Margaret Chesney
Journal:  Clin Infect Dis       Date:  2002-03-11       Impact factor: 9.079

8.  Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG).

Authors:  M A Chesney; J R Ickovics; D B Chambers; A L Gifford; J Neidig; B Zwickl; A W Wu
Journal:  AIDS Care       Date:  2000-06

9.  Marijuana use among HIV-positive and high-risk adolescents: a comparison of self-report through audio computer-assisted self-administered interviewing and urinalysis.

Authors:  D A Murphy; S Durako; L R Muenz; C M Wilson
Journal:  Am J Epidemiol       Date:  2000-11-01       Impact factor: 4.897

10.  Factor structure, concurrent validity, and internal consistency of the Beck Depression Inventory-Second Edition in a sample of college students.

Authors:  Eric A Storch; Jonathan W Roberti; Deborah A Roth
Journal:  Depress Anxiety       Date:  2004       Impact factor: 6.505

View more
  31 in total

1.  Associations between Pain-Related Anxiety, Gender, and Prescription Opioid Misuse among Tobacco Smokers Living with HIV/AIDS.

Authors:  Lisa R LaRowe; Lauren N Chilcott; Michael J Zvolensky; Peter A Vanable; Kelley Flood; Joseph W Ditre
Journal:  Subst Use Misuse       Date:  2018-04-30       Impact factor: 2.164

Review 2.  Instruments to Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: An ACTTION Systematic Review.

Authors:  Shannon M Smith; Florence Paillard; Andrew McKeown; Laurie B Burke; Robert R Edwards; Nathaniel P Katz; Elektra J Papadopoulos; Bob A Rappaport; Ashley Slagle; Eric C Strain; Ajay D Wasan; Dennis C Turk; Robert H Dworkin
Journal:  J Pain       Date:  2015-02-04       Impact factor: 5.820

Review 3.  Substance Use and Adherence to Antiretroviral Therapy: What Is Known and What Is Unknown.

Authors:  M Eugenia Socias; M-J Milloy
Journal:  Curr Infect Dis Rep       Date:  2018-07-31       Impact factor: 3.725

4.  High levels of self-reported prescription opioid use by HIV-positive individuals.

Authors:  Abigail Norris Turner; Courtney Maierhofer; Nicholas T Funderburg; Brandon Snyder; Kristi Small; Jan Clark; Jose A Bazan; Nicole C Kwiek; Jesse J Kwiek
Journal:  AIDS Care       Date:  2016-06-20

5.  High-intensity cannabis use and HIV clinical outcomes among HIV-positive people who use illicit drugs in Vancouver, Canada.

Authors:  Stephanie Lake; Thomas Kerr; Rielle Capler; Jeannie Shoveller; Julio Montaner; M-J Milloy
Journal:  Int J Drug Policy       Date:  2017-03-21

6.  Measures That Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: ACTTION Critique and Recommended Considerations.

Authors:  Shannon M Smith; Judith K Jones; Nathaniel P Katz; Carl L Roland; Beatrice Setnik; Jeremiah J Trudeau; Stephen Wright; Laurie B Burke; Sandra D Comer; Richard C Dart; Raymond Dionne; J David Haddox; Jerome H Jaffe; Ernest A Kopecky; Bridget A Martell; Ivan D Montoya; Marsha Stanton; Ajay D Wasan; Dennis C Turk; Robert H Dworkin
Journal:  J Pain       Date:  2017-05-04       Impact factor: 5.820

7.  Opioids and HIV Infection: From Pain Management to Addiction Treatment.

Authors:  Chinazo O Cunningham
Journal:  Top Antivir Med       Date:  2018-04

8.  Opioid Misuse as a Predictor of Alcohol Treatment Outcomes in the COMBINE Study: Mediation by Medication Adherence.

Authors:  Katie Witkiewitz; Victoria R Votaw; Kevin E Vowles; Henry R Kranzler
Journal:  Alcohol Clin Exp Res       Date:  2018-06-09       Impact factor: 3.455

9.  Use of Nonantiretroviral Medications That May Impact Neurocognition: Patterns and Predictors in a Large, Long-Term HIV Cohort Study.

Authors:  Kendra K Radtke; Peter Bacchetti; Kathryn Anastos; Daniel Merenstein; Howard Crystal; Roksana Karim; Kathleen M Weber; Andrew Edmonds; Anandi N Sheth; Margaret A Fischl; David Vance; Ruth M Greenblatt; Leah H Rubin
Journal:  J Acquir Immune Defic Syndr       Date:  2018-06-01       Impact factor: 3.731

10.  The impact of prescribed opioids on CD4 cell count recovery among HIV-infected patients newly initiating antiretroviral therapy.

Authors:  E J Edelman; K S Gordon; J P Tate; W C Becker; K Bryant; K Crothers; J R Gaither; C L Gibert; A J Gordon; Bdl Marshall; M C Rodriguez-Barradas; J H Samet; M Skanderson; A C Justice; D A Fiellin
Journal:  HIV Med       Date:  2016-11       Impact factor: 3.180

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.